In India, a two-brother team built Minimalist from zero to a ₹2,706 crore all-cash sale to Hindustan Unilever in four years — profitably, every single year. The playbook is public. Pakistan has the same demand, the same trust deficit, and nobody filling the gap.
Pakistani consumers learned the language of active ingredients from TikTok. They know what niacinamide does. They can't afford to buy it.
Niacinamide, salicylic acid, retinol and hyaluronic acid are household terms among Pakistani women now, driven by local beauty creators. The education has already happened — someone else paid for it.
Formal duty-paid imports run PKR 4,400–7,500. But grey-market importers sell the identical product at PKR 1,600–3,500, with no warranty, no batch traceability and demonstrable counterfeits alongside. Buyers choose between unaffordable and untrustworthy.
What's cheap locally is mercury-and-steroid whitening cream, or vague "herbal" positioning. There is no honest, affordable, accountable option. That is the opportunity — and it is a trust gap more than a price gap.
Grey-market The Ordinary niacinamide against our target price. Not the PKR 9,000 shelf price — that channel has already lost the volume. Naheed doesn't even stock The Ordinary's best-selling niacinamide while parallel importers stock it heavily. So we are not competing on price against imports. We're competing on accountability against a grey market with no warranty, no batch traceability and counterfeits in plain sight.
Founded 2020 in Jaipur by two brothers — Mohit Yadav, a chartered accountant, and Rahul Yadav, an IIT Roorkee engineer. Legal entity Uprising Science Private Limited. Hindustan Unilever acquired 90.5% for ₹2,706 crore in cash — announced January 2025, completed April 2025, at a ₹2,955 crore pre-money valuation, with the balance to be bought from the founders within two years. Among the largest in Indian D2C (direct-to-consumer) history.
Widely repeated write-ups say Minimalist "did ₹100 crore in eight months." That was an annualised run-rate, not turnover — the founder said so in a 2021 interview, and the filed accounts confirm it (FY21 booked ₹21.6cr). Booked revenue crossed ₹100cr in FY22, its second fiscal year. Those same write-ups also report FY24 profit as ₹1 crore; the filings say ₹10.9 crore. We use the filed figures throughout, because the inflated versions don't survive a diligence check — and the honest ones are still remarkable.
Their research found 79% of beauty industry claims misleading. Their answer was a public, aggressive stance: "Everything is a chemical — water is a chemical — therefore chemical-free products don't exist."
While competitors used outside manufacturers and put ~90% of funds into marketing, Minimalist built their own plant. Their filings declare 100% of turnover from "manufacture of chemicals and chemical products."
Contacted buyers three months after purchase and filmed the ones with genuine results. Marketing reportedly held near 25% of revenue against a 40–45% norm unverified — but the profitability is documented, and low marketing spend is the only way it adds up.
A single SKU (one sellable item) for the first five to six months; five or six by end of year one. The restraint concentrated stock risk and marketing spend behind one proof point.
International active brands sold at ₹1,000–2,000+. Minimalist sat at ₹500–600 by capping profit margin and cutting marketing. Their median SKU is still ₹549 today and 82% of their range sits under ₹700.
Commentary widely cites a "60% repeat rate versus a 15–20% industry average." Neither half has a traceable source. Competing figures of 42/45/60/65% circulate; it appears in no founder interview and in none of Unilever's acquisition communications — which an acquirer would surely have mentioned. We treat retention as something we must prove, not borrow. See §05.
Over half of sales came from tier-3 towns and rural areas, reached through educational content rather than shop presence. Then Nykaa, Amazon, and finally physical shops.
Selling online scales quickly; getting into millions of small shops takes decades. Unilever reaches 9 million retail outlets across 100+ countries. Selling bought them distribution they could never have built.
Pakistan's skin complaints come from a specific environment: 35–45°C for eight to nine months, coastal humidity, seasonal smog, year-round UV. Layered on Fitzpatrick III–V (medium-to-deep South Asian skin tones), which readily develops post-inflammatory hyperpigmentation (the dark mark a pimple leaves behind).

Controls oil in humidity without drying the skin out. Also shields against city smog.

Dissolves in oil, so it reaches grime trapped inside pores. Replaces scratchy walnut scrubs that tear skin.

The safe answer to what whitening creams currently promise. Stays stable in heat, unlike vitamin C.
Product photography is Minimalist India's, shown only as reference for packaging and labelling convention.
Minimalist launched with one product and held it for five to six months. We propose three — tripling the cash tied up in the first production run and splitting content effort three ways. But oil, spots and dark marks are genuinely different problems, and one product serves about a third of the market. The mitigation: launch all three, but put the entire advertising budget behind whichever produces the strongest early customer videos. The other two ride on word of mouth and bundles until they earn spend.
An invisible, non-greasy SPF 50 sunscreen. The ingredients create the need — both alpha arbutin and salicylic acid increase photosensitivity (they make skin burn more easily), so selling them in a country this sunny without sunscreen leaves the routine incomplete.
Everything is a chemical. Water is a chemical. Therefore chemical-free products don't exist.
The defensible asset isn't the formula — active ingredients are commodities and any competent lab can make a 10% niacinamide serum. It's the disclosure format. Minimalist's product pages do eleven specific things, every time. Each is individually cheap. Doing all of them is what buys the trust.
Not "Clarifying Serum." Niacinamide 10% Face Serum. The percentage is the name.
Always the fourth chip. 5.5–6.5 for niacinamide, 3.2–4.0 for salicylic. Almost nobody does this.
"Our Niacinamide comes from Lonza, Switzerland." "Salicylic Acid from Merck, Germany." Naming your supplier makes the claim checkable.
The complete INCI (standard ingredient naming) list on the page. Not an image, not a PDF. Searchable.
"Base ₹483 · 18% tax ₹87 · Total ₹570." You see exactly what goes to the government.
The international test standard, the study reference, the independent lab named, and a scan of the report embedded.
Their SPF 50 sunscreen actually tested at 56.6. They still label it 50. In a market built on exaggeration this is the strongest signal available.
One product's entire results section reads: "evaluated for safety through patch testing under the supervision of a Dermatologist." That's all of it. No invented statistics.
3.9754977 out of 5, to seven decimal places, from 1,306 reviews. One-star reviews left visible and unfiltered.
"No. This sunscreen uses Octocrylene… we recommend avoiding it during pregnancy or breastfeeding." They talk customers out of the sale.
A full explanation of "purging" — skin getting worse before better — why it happens, that it lasts three to four weeks, and advice to push through rather than quit.
India's enemy was greenwashing. Pakistan's enemy is the whitening cream — mercury and steroid formulas that damage the skin barrier while promising fairness. Same move, sharper local target: chemicals aren't the enemy; unlabelled chemicals are. Every claim we make must be one a dermatologist would sign.
Rather than describe the disclosure format, here it is. These are Minimalist's own product-page panels, pulled directly from their catalogue. Switch product and panel to see how rigidly the same template repeats — that consistency is the asset.
Pick a size. The smallest bottle is the cheapest thing on the shelf and the most profitable per millilitre — that's the whole mechanic, and it's why our Pakistani version has to be bundled rather than sold alone.
Their SPF page cites an ISO 24444 lab report with a study number and embeds a scan of it. That scan is not in the product image gallery — it sits inside the description accordion, so it isn't in the catalogue data. Worth noting because it's the single strongest trust artefact they publish, and a Pakistani brand would need to produce its own equivalent rather than borrow the idea alone.
All panels are Minimalist India's own catalogue assets, reproduced as evidence of the disclosure format under discussion. Their customer before/after photographs are deliberately excluded — those show identifiable individuals and are not ours to republish.
Unit economics (the profit and loss on one single sale) for a 30ml serum sold at PKR 1,500 and delivered to the door, at standard Pakistani courier rates for a parcel under half a kilo.
PKR 1,200 left after making it
PKR, after delivery and returns
PKR — the actual profit
Below this, every sale loses money
Every number here is an assumption. Move the sliders to see which ones actually matter — and how fast a profitable bottle becomes a loss-making one.
The gap between plan (3.0x) and breakeven (1.74x) reads as comfortable, but the cost of finding each customer rises as you exhaust the cheap early audience — that's the normal shape of advertising, not a failure. Watch the seven-day average across all spend, not what individual campaigns report, because campaign figures quietly ignore orders you paid to acquire and then failed to deliver.
Minimalist's cleverest trick is the 10ml trial bottle at ₹249 — a third of the liquid at roughly 43% of the price, which quietly earns them more profit per millilitre, not less. It removes the price objection for a first-time buyer. We modelled it for Pakistan. On its own it doesn't work here — and the reason is structural, not something better pricing can fix.
| Format | Price | Delivery as % of order | Left before ads | Breakeven | Profit at PKR 500 ad cost |
|---|---|---|---|---|---|
| 30ml full size | 1,500 | 14.7% | 860 | 1.74x | +360 |
| 10ml trial, on its own | 650 | 33.8% | 179 | 3.63x | −321 |
| 3 × 10ml routine kit | 1,650 | 13.3% | 822 | 2.01x | +322 |
| 2 × 30ml bundle | 2,600 | 8.5% | 1,608 | 1.62x | +1,108 |
← swipe the table sideways to see all columns
Courier cost in Pakistan is effectively fixed at ~PKR 220 per parcel whatever's inside. That's 15% of a PKR 1,500 order but 34% of a PKR 650 trial — it eats the entire margin before a rupee of advertising. Any order below roughly PKR 1,000 is structurally unprofitable here. The fix isn't to abandon the trial size, it's to bundle it: three 10ml bottles at PKR 1,650 brings delivery back to 13% and works.
Everything above assumes one customer buying once. The first order carries the full acquisition cost; every order after it does not. That asymmetry is the model.
We had planned to borrow Minimalist's reported 60% repeat rate. Verification found it has no traceable source — so retention is modelled here as the variable we must prove, across the full plausible range.
| Contribution | First order | Each repeat order |
|---|---|---|
| Selling price | 1,500 | 1,500 |
| Product, courier, packaging, confirmation | −570 | −570 |
| Failed-delivery reserve | −70 (15%) | −28 (6%) |
| Loyalty accrual + retention contact | — | −100 |
| Contribution before acquisition cost | 860 | 802 |
Repeat buyers fail delivery far less often — a known-good address and phone number that has already accepted a parcel once. That, more than anything, is why repeat orders are worth what they are.
At the planned PKR 500 acquisition cost, we need a 34.5% second-order rate to reach a healthy 3:1 lifetime-value ratio. Industry commentary puts the viability threshold for beauty D2C at 25–30% repeating within three months — so the target is achievable, but it sits above the category's own definition of viable. It is not a comfortable assumption.
The failure mode is CAC drift, not a bad month. If acquisition cost creeps to PKR 900, required retention jumps to 49% — beyond anything credibly documented for the category.
Payback is one order. Contribution on the first order (PKR 860) exceeds the acquisition cost (PKR 500) at every retention level. The business is cash-positive on order one.
That matters more here than it would elsewhere. In a cash-on-delivery market, working capital kills companies, not unprofitability — cash sits trapped in stock and in orders delivered but not yet settled by the courier. Most D2C brands need two or three orders to recover acquisition cost and need funding to survive the gap. This one funds growth from its own cash cycle. It is a stronger claim than any retention assertion, and unlike them, it follows from arithmetic we can show.
We don't advertise by shouting about the brand. We teach people what the ingredients do, using videos from real customers, and the selling happens on its own.
Spark Ads (paying to boost a real person's existing TikTok) convert better and cost less than brand films. Micro-creators and skin-focused accounts, filmed only once they have real results. Strictly ingredient education in conversational Urdu.
New videos are tested in isolation with everything else held constant (the "ABO" structure — each ad gets its own fixed budget). Only once a video makes money on its own does it move into the main campaign ("CBO" — one shared budget the platform pushes toward whatever performs).
Cash on delivery is 60–70% of B2C transactions — Ministry of Commerce e-Commerce Policy 2025, which targets under 30% by 2027. Our 15% failed-delivery assumption is ours: no independent source publishes one, and every figure in circulation comes from a vendor selling the fix. PostEx publishes 92% delivery success, implying ~8%. We model 15% deliberately — wrong in the safe direction. WhatsApp confirmation before dispatch must be running before the first rupee of advertising.
With a third of revenue going into advertising, how quickly cash returns matters more than margin. Some couriers pay out cash-on-delivery takings early, letting spend recycle instead of waiting weeks. Working capital (cash stuck in stock and unpaid orders), not profitability, is what kills COD businesses.
A certified local manufacturer samples formulas that survive 45°C without separating. Light, fast-absorbing texture — in this heat a tacky serum doesn't get re-ordered, which makes texture a financial problem, not a cosmetic one. In parallel: settle the import-licensing question, get real courier return rates, lock packaging.
Shop, courier integration and WhatsApp confirmation all live before any advertising. All three serums on sale; the entire budget behind whichever generates the strongest early customer videos.
The number that decides everything. How many first-time buyers order again within 60 and 90 days determines what we can afford to spend finding them — and whether this is a business or a treadmill.
Sunscreen completes the routine and raises order value. Bundles fix the delivery-cost problem. Pharmacies and retail only once repeat purchasing is proven — the step that eventually made Minimalist worth buying.
Prices below were pulled from each retailer's own server on 2 August 2026 — not from aggregators. They changed our pricing thesis materially.
| Player | 30ml active serum | Position |
|---|---|---|
| Formal duty-paid imports (Naheed, Al-Fatah) | 4,400 – 7,500 | The channel our original thesis benchmarked against — and the one that has already lost the volume. |
| AccuFix Cosmetics | 2,095 – 3,495 | Science-based local. Uses strength-tiered pricing, +PKR 100 per potency step. |
| Jenpharm (NiaRonic / MandelAC) | 1,598 – 1,998 | The serious competitor. Dermatologist-backed, 65 SKUs, free shipping, free samples, 10% bundle discounts. Their NiaRonic is 10% niacinamide + zinc + HA — our product, already on shelf. |
| Grey-market The Ordinary | 1,600 – 3,500 | The real price anchor. Parallel importers on Shopify. No warranty, no batch traceability, counterfeits present — one Daraz listing reads "Oerdinary" at PKR 784. |
| Us | 1,500 | 6% under Jenpharm's cheapest serum. 16% under grey-market The Ordinary. |
| Whitening creams | ~550 – 850 | The incumbent by volume, and where the customers actually come from. Alpha arbutin serves the same want, safely. |
← swipe the table sideways to see all columns
Earlier drafts of this document claimed we would sell "the same category at a third of the price." Against the real competitive set, that is false. It holds only against the formal import channel — and most price-aware Pakistani buyers have already routed around it. Naheed doesn't even stock The Ordinary's best-selling niacinamide while grey importers stock it heavily.
Against Jenpharm's MandelAC at PKR 1,598 we are 6% cheaper. Against grey-market The Ordinary at PKR 1,780, 16%. That is not an arbitrage; it is a rounding error.
So the wedge cannot be price. It has to be accountability. Grey-market goods carry no warranty, no batch number, no recourse, and demonstrable counterfeits. A licensed local brand publishing its concentrations, its pH, its supplier and its batch is selling something the cheap channel structurally cannot: somebody to hold responsible. That is a better wedge anyway — it's defensible, and price never is.
This is a concept study, not a completed plan. Presenting it as finished would be the first dishonest thing in a project whose entire premise is honesty.
Non-medicated cosmetics fall under PSQCA, not DRAP — skincare doesn't appear on DRAP's import control list at all, and the fee and approval burden on that route is modest. Classification does, however, turn on the claims made rather than the formula alone, and a synthetic-actives line sits close to the boundary. A written classification opinion is step one, and it also determines the promotional-spend rules that apply. Full regulatory detail, including the relevant SROs and fee schedule, available on request.
Our PKR 70 reserve assumes 15% of parcels fail at an assumed cost each. Without the courier's actual return fee schedule we can't calculate the point at which failed deliveries wipe out profit — the single largest operational risk in Pakistani online retail.
Minimalist deliberately kept only 65% margin, putting ₹350 of raw material into every ₹1,000 sold. Our model keeps 80% — only 20% goes into the product. Pakistan's delivery costs may justify it, but "we put more in the bottle than anyone else" is the brand's central claim. This must be a decision, not a default.
The 60% repeat rate we planned to build on has no traceable source, so §05 now models retention across its full range. We need 34.5% of buyers to order again to justify a PKR 500 acquisition cost. Achievable — the category's own viability threshold is 25–30% — but above it. The whole plan rests on a number nobody has measured yet.
The USD 5.10bn and USD 496.6m figures are Statista modelled estimates behind a paywall — no reader can check them. They aren't independent either: the second comes from ECDB, a Statista company. And its category is mass FMCG — shampoo, toothpaste, nappies — not a serum market. Statista's own CAGR for it is 2.18%, below dollar inflation. Removed from this document rather than dressed up.
Earlier drafts proposed a 14-day results guarantee to overcome the trust problem. Minimalist offers nothing of the kind — returns only for damaged or wrong items, seven days, photo required. They bought trust with disclosure, which costs nothing per order. A results guarantee in a cash-on-delivery market with existing fraud is a very different risk.
Five things to resolve, in this order. None of them needs capital — which is the point.
| # | Action | Why it comes first |
|---|---|---|
| 1 | Obtain a written product-classification opinion | Determines the licensing route, the fee burden and the promotional-spend rules that apply. One consultation, and it should precede any capital commitment. |
| 2 | Rebuild the positioning around accountability, not price | Verified competitor pricing killed the price wedge — we're 6% under Jenpharm, not a third of the price. The trust gap against the grey market is the real opening. |
| 3 | Get PostEx's actual rate card and failed-delivery fees | They publish nothing. Our PKR 220 and PKR 70 are placeholders until a real quote replaces them. |
| 4 | Decide the margin: 65% or 80% | Determines pricing, formulation budget, and whether the honesty claim is defensible. |
| 5 | Design the retention instrumentation before launch, not after | The 60- and 90-day second-order rate is the single leading indicator. It has to be measurable from the first cohort. |
The concept is viable — on narrower and more defensible grounds than it first appeared. The original thesis, sell the same product at a third of the import price, does not survive contact with the actual market. Pakistani competitors already sell 10% niacinamide at PKR 1,598–2,095, and grey importers undercut the formal channel by two thirds.
What does survive is better evidenced and harder to copy:
The open questions are answerable — a classification opinion, a courier rate card, a margin decision, and a retention rate that can only be learned by trading. None of them requires capital to resolve. That, more than any projection on this page, is the argument for taking the next step.
Hover or tap any dotted term above to see these inline.